Ask AI
ANCHOR
ANCHOR: Phase III Trial of Anlotinib or Bevacizumab With 1L Chemotherapy for RAS/BRAF Wild-Type Unresectable mCRC

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025